Materias dentro de su búsqueda.
Mostrando 3,041 - 3,060 Resultados de 5,148 Para Buscar '"Ph. D."', tiempo de consulta: 0.95s Limitar resultados
  1. 3041
    “…Cosgrove, MD, MS, Debiopharm: Advisor/Consultant|Duke Clinical Research Institute: Advisor/Consultant Sean Zhang, MD, PhD, Applied BioCode: Grant/Research Support|IMMY Diagnostics: Grant/Research Support|KARIUS: Advisor/Consultant|Pearl Diagnostics: Grant/Research Support|Scanogen: Grant/Research Support|T2 biosystems: Advisor/Consultant|Vela Diagnostics: Grant/Research Support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2460. Understanding acquisition of Candida glabrata in the healthcare setting
  2. 3042
    “…DISCLOSURES: Kelly R. Reveles, PharmD, PhD, Ferring Pharmaceuticals: Advisor/Consultant|Ferring Pharmaceuticals: Honoraria Anne J. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    702. Efficacy of Fecal Microbiota, Live-jslm After Receipt of Non–Clostridioides difficile Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label Trial
  3. 3043
    “…[Figure: see text] DISCLOSURES: Elkin Lemos-Luengas, MD MSc PhD, Pfizer Colombia: Honoraria Sixta Romelia Rentería-Valoyes, Md, Pfizer: Senior Associate Medicines Business /Medical Scientific Liaison MD for Pfizer Colombia Diana Marcela Almario Muñoz, MD, MSc, Pfizer Colombia: Medical Scientific Liaison Carlos David Gamboa Orozco, Md, Pfizer: Medical Scientific Liaison for Pfizer Colombia Juan Camilo Olivella Gómez, n/a, Pfizer Colombia: Medical Student Jorge Ramos-Castaneda, PhD, Pfizer: Advisor/Consultant…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2782. In vitro activity of ceftazidime-avibactam against Gram-negative strains in patients with bacteremia and skin and soft-tissue infections in Colombia 2019-2021
  4. 3044
    “…DISCLOSURES: Cecilia G. Carvalhaes, MD, PhD, AbbVie: Grant/Research Support|bioMerieux: Grant/Research Support|Cipla: Grant/Research Support|CorMedix: Grant/Research Support|Melinta: Grant/Research Support|Pfizer: Grant/Research Support Paul Rhomberg, BS, MT(ASCP), bioMerieux: Grant/Research Support|Melinta: Grant/Research Support|Pfizer: Grant/Research Support Abby L. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2113. Evaluation of Isavuconazole Activity against Aspergillus fumigatus Causing Invasive Infections Worldwide Using the New CLSI Clinical Breakpoints
  5. 3045
    “…DISCLOSURES: Hiroaki Baba, MD, PhD, Amano Co., Ltd.: Grant/Research Support Hajime Kanamori, MD, PhD, MPH, Amano Co., Ltd.: Grant/Research Support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2454. Deep detection of antimicrobial resistance genes in hospital wastewater using the multiplex hybrid capture method
  6. 3046
    “…Grad, MD, PhD, Day Zero Diagnostics: Board Member|GSK: Advisor/Consultant…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2478. Trends in antibiotic resistance for nine pathogens in the US Veterans Affairs Healthcare System from 2007 to 2022
  7. 3047
    “…Stamm, MD, PhD, Bill & Melinda Gates Medical Research Institute: Salary as a full-time employee Michael W. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    383. Pharmacokinetics and Safety in Healthy Adults of RSM01, a Novel RSV Monoclonal Antibody, and Population PK Modeling to Support Pediatric Development
  8. 3048
    “…The final data analytic and interpretative core team consisted of four data science students, two PhD students, an undergraduate biology major, a recent medical graduate, and a PhD research scientist. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    3165 Diseased and Healthy Gastrointestinal Tissue Data Mining requires an Engaged Transdisciplinary team
  9. 3049
    “…This has led to perceptions that they cannot compete effectively with PhDs and MD-PhD scientists for research funding and positions. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    3292 Duke Integrated Physician-Scientist Development
  10. 3050
    “…Langley, MD, VBI Vaccines (Grant/Research Support), Johanna Spaans, BSc, MSc, VBI Vaccines (Employee), Nathalie Machluf, PhD, SciVac Ltd. (Employee), Dave Anderson, PhD, VBI Vaccines, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LB13. Trivalent Hepatitis B (HepB) Vaccine Yields Superior Seroprotection Rates in Adults: Results from the Phase 3 Double-Blind, Randomized Study Comparing Immunogenicity and Safety of a 3-Dose Regimen of Sci-B-Vac™ and Engerix B® (PROTECT)
  11. 3051
    “…Shepard, PhD, Sanofi Pasteur (Grant/Research Support) Natasha B. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    913. Distribution of Respiratory Viral Pathogens in Infants Across Different Clinical Settings from December 2019 to April 2020
  12. 3052
    “…Geometric mean fold rise in nasal mucosal secretory IgA antibody titers after vaccination [Image: see text] DISCLOSURES: Joseph Eiden, MD, PhD, FluGen (Consultant) Ruth Ellis, MD, FluGen (Consultant) Roger Aitchison, ScM, FluGen (Consultant) Renee Herber, BS, FluGen (Employee) Pamuk Bilsel, PhD, FluGen (Employee)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    33. Intranasal M2SR (M2-deficient Single Replication) Live H3N2 Influenza Investigational Vaccine Induces Serum HAI & Broad Immune Responses in High Proportion of Adults
  13. 3053
    “…FUNDING: GlaxoSmithKline Biologicals SA DISCLOSURES: Marta Lopez Fauqued, PhD, GSK group of companies (Employee) Maribel Miranda Co, MD, GSK group of companies (Employee) Adriana Bastidas, MD, GSK group of companies (Shareholder, Former employee) Pierre Beukelaers, PhD, GSK group of companies (Employee) Alemnew F. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    37. Safety Profile of the Adjuvanted Recombinant Zoster Vaccine (RZV) in Immunocompromised Populations: an Overview of 6 Trials
  14. 3054
    “…Langley, MD, GSK group of companies (Research Grant or Support)Immunivaccines Inc (Scientific Research Study Investigator, Research Grant or Support)Janssen (Research Grant or Support)Pfizer (Research Grant or Support)Symvivo (Scientific Research Study Investigator, Research Grant or Support)VBI Vaccines (Research Grant or Support) Nathalie Machluf, PhD, VBI Vaccines Inc. (Employee) Johanna Spaans, BSc, MSc, VBI Vaccines Inc (Employee) Dave Anderson, PhD, VBI Vaccines (Employee, Shareholder) Vlad Popovic, MD, VBI Vaccines, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    8. Higher hepatitis B antibody titres induced in all adults vaccinated with a tri-antigenic hepatitis B (HBV) vaccine, compared to a mono-antigenic HBV vaccine: results from two pivotal phase 3 double-blind, randomized studies (PROTECT and CONSTANT)
  15. 3055
    “…DISCLOSURES: Adam Belley, PHD, Allecra Therapeutics SAS (Consultant) Philip Barth, MD, Allecra Therapeutics SAS (Consultant) Shikhar Kashyap, n/a, Allecra Therapeutics SAS (Consultant)Allecra Therapeutics SAS (Consultant) Omar Lahlou, PhD, Allecra Therapeutics SAS (Employee) Paola Motta, PhD, Allecra Therapeutics SAS (Employee) Patrick Velicitat, MD, Allecra Therapeutics SAS (Employee)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LB-4. Cefepime-Enmetazobactam Demonstrates Superiority to Piperacillin-Tazobactam in a Subgroup of Patients with Complicated Urinary Tract Infections/Acute Pyelonephritis Caused by Extended Spectrum β-Lactamase-Producing Enterobacterales
  16. 3056
    “…Muir, n/a, Spero Therapeutics (Employee)Spero Therapeutics (Employee, Shareholder) Susannah M. Walpole, PhD, Spero Therapeutics, Inc. (Employee) Hanna Kwak, n/a, Spero Therapeutics (Employee) Anne-Marie Phelan, n/a, Spero Therapeutics (Employee)Spero Therapeutics (Employee, Shareholder) Gary E. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LB-3. Oral Tebipenem Pivoxil Hydrobromide is Non-inferior to IV Ertapenem in Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP) – Results from the Pivotal ADAPT-PO Study
  17. 3057
    “…(Consultant) Toshihiro Wajima, PhD, Shionogi & Co., Ltd. (Employee)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1316. Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol in Critically Ill Patients
  18. 3058
    “…Langley, MD, GSK group of companies (Research Grant or Support)Immunivaccines Inc (Scientific Research Study Investigator, Research Grant or Support)Janssen (Research Grant or Support)Pfizer (Research Grant or Support)Symvivo (Scientific Research Study Investigator, Research Grant or Support)VBI Vaccines (Research Grant or Support) Nathalie Machluf, PhD, VBI Vaccines Inc. (Employee) Johanna Spaans, BSc, MSc, VBI Vaccines Inc (Employee) Dave Anderson, PhD, VBI Vaccines (Employee, Shareholder) Vlad Popovic, MD, VBI Vaccines, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1051. Rapid onset of seroprotection rates in young adults immunized with a tri-antigenic hepatitis B virus (HBV) vaccine compared to a mono-antigenic HBV vaccine
  19. 3059
    “…DISCLOSURES: Paula Teichner, PharmD, GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee) Sterling Wu, PhD, GlaxoSmithKline (Employee, Shareholder) David Dorey, MMATH, GlaxoSmithKline Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1029. Long-Term Patient Adherence and Management of Treatment Interruptions With Long-Acting Injectable Cabotegravir + Rilpivirine for Maintenance Therapy in Phase IIb/III Studies
  20. 3060
    “…DISCLOSURES: Maggie Czarnogorski, MD, MPH, ViiV Healthcare (Employee) Cindy Garris, MSPH, GlaxoSmithKline (Other Financial or Material Support, Stockholder)ViiV Healthcare (Employee) Paul Wannamaker, BA, ViiV Healthcare (Employee) Ronald D’Amico, DO, MSc, GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee) Carolyn Selenski, PhD, GSK (Employee, Shareholder) Colleen A. McHorney, PhD, Evidera (Employee) Larissa Stassek, MPH, Evidera (Employee) Gary I. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1037. Qualitative Findings from a Hybrid III Implementation-Effectiveness Study to Explore Perspectives of Health-care Staff on Early Implementation of Cabotegravir and Rilpivirine Long Acting (CAB+RPV LA) Injectable HIV treatment in the US (CUSTOMIZE)
Herramientas de búsqueda: RSS